⌘K

Login Start Free

Home/Filings/4/0001142576-10-000032

4//SEC Filing

Shue Youe Kong 4

Accession 0001142576-10-000032

CIK 0001142576other

View on SEC.gov Company Profile

Filed

Aug 31, 8:00 PM ET

Accepted

Sep 1, 4:55 PM ET

Size

14.2 KB

Accession

0001142576-10-000032

Insider Transaction Report

Form 4

Period: 2010-08-30

OPTIMER PHARMACEUTICALS INCOPTR

VP, clinical Development

Transactions

Exercise/Conversion
Common stock
2010-08-30$2.17/sh+4,326$9,373→ 90,107 total
Exercise/Conversion
Common stock
2010-08-30$1.08/sh+1,875$2,031→ 85,781 total
Exercise/Conversion
Stock option (right to buy)
2010-08-30−4,326→ 0 total
Exercise: $2.17Exp: 2016-09-13→ Common stock (4,326 underlying)
Exercise/Conversion
Stock option (right to buy)
2010-08-30−1,875→ 0 total
Exercise: $1.08Exp: 2013-11-14→ Common stock (1,875 underlying)
Exercise/Conversion
Common stock
2010-08-30$1.08/sh+97$105→ 83,906 total
Exercise/Conversion
Stock option (right to buy)
2010-08-30−97→ 0 total
Exercise: $1.08Exp: 2013-02-13→ Common stock (97 underlying)

Footnotes (1)

[F1]Options are exercisable immediately.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

OPTIMER PHARMACEUTICALS INC

CIK 0001142576

Entity typeother

Related Parties

1

filerCIK 0001380841

Filing Metadata

Form type: 4
Filed: Aug 31, 8:00 PM ET
Accepted: Sep 1, 4:55 PM ET
Size: 14.2 KB

View on SEC.gov